Functional deficiency of aryl hydrocarbon receptor augments oxygen toxicity-induced alveolar simplification in newborn mice

Toxicology and Applied Pharmacology

Volumn 267, Issue 3, 2013, Pages 209-217

  Shivanna, Binoy ^a   Zhang, Wenyan ^a   Jiang, Weiwu ^a   Welty, Stephen E ^a   Couroucli, Xanthi I ^a   Wang, Lihua ^a   Moorthy, Bhagavatula ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Alveolar simplification; Aryl hydrocarbon receptor; Hyperoxia; Lung inflammation

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; GLUTATHIONE TRANSFERASE; OXIDOREDUCTASE; OXYGEN;

ALVEOLAR SIMPLIFICATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPEROXIA; LUNG DIFFUSION; MOUSE; NEWBORN; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; HYPEROXIA; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, KNOCKOUT; OXYGEN; PULMONARY ALVEOLI; RANDOM ALLOCATION; RECEPTORS, ARYL HYDROCARBON;

EID: 84873422029     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.01.003     Document Type: Article

References (51)

1. Abbott B.D., Birnbaum L.S., Perdew G.H. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev. Dyn. 1995, 204:133-143.
2. Ambalavanan N., Carlo W.A., D'Angio C.T., McDonald S.A., Das A., Schendel D., Thorsen P., Higgins R.D. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 2009, 123:1132-1141.
3. Asikainen T.M., White C.W. Antioxidant defenses in the preterm lung: role for hypoxia-inducible factors in BPD?. Toxicol. Appl. Pharmacol. 2005, 203:177-188.
4. Baglole C.J., Maggirwar S.B., Gasiewicz T.A., Thatcher T.H., Phipps R.P., Sime P.J. The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J. Biol. Chem. 2008, 283:28944-28957.
5. Benson A.M., Hunkeler M.J., Talalay P. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Proc. Natl. Acad. Sci. U. S. A. 1980, 77:5216-5220.
6. Bhandari V. Hyperoxia-derived lung damage in preterm infants. Semin. Fetal Neonatal Med. 2010, 15:223-229.
7. Bock K.W., Kohle C. The mammalian aryl hydrocarbon (Ah) receptor: from mediator of dioxin toxicity toward physiological functions in skin and liver. Biol. Chem. 2009, 390:1225-1235.
8. Burbach K.M., Poland A., Bradfield C.A. Cloning of the Ah-receptor cDNA reveals a distinctive ligand-activated transcription factor. Proc. Natl. Acad. Sci. U. S. A. 1992, 89:8185-8189.
9. Chang C., Smith D.R., Prasad V.S., Sidman C.L., Nebert D.W., Puga A. Ten nucleotide differences, five of which cause amino acid changes, are associated with the Ah receptor locus polymorphism of C57BL/6 and DBA/2 mice. Pharmacogenetics 1993, 3:312-321.
10. Cho H.Y., Jedlicka A.E., Reddy S.P., Kensler T.W., Yamamoto M., Zhang L.Y., Kleeberger S.R. Role of NRF2 in protection against hyperoxic lung injury in mice. Am. J. Respir. Cell Mol. Biol. 2002, 26:175-182.
11. Clement A., Chadelat K., Sardet A., Grimfeld A., Tournier G. Alveolar macrophage status in bronchopulmonary dysplasia. Pediatr. Res. 1988, 23:470-473.
12. Clerch L.B. Post-transcriptional regulation of lung antioxidant enzyme gene expression. Ann. N. Y. Acad. Sci. 2000, 899:103-111.
13. Cooney T.P., Thurlbeck W.M. The radial alveolar count method of Emery and Mithal: a reappraisal 1-postnatal lung growth. Thorax 1982, 37:572-579.
14. Couroucli X.I., Welty S.E., Geske R.S., Moorthy B. Regulation of pulmonary and hepatic cytochrome P4501A expression in the rat by hyperoxia: implications for hyperoxic lung injury. Mol. Pharmacol. 2002, 61:507-515.
15. Couroucli X.I., Liang Y.H., Jiang W., Wang L., Barrios R., Yang P., Moorthy B. Prenatal administration of the cytochrome P4501A inducer, beta-naphthoflavone (BNF), attenuates hyperoxic lung injury in newborn mice: implications for bronchopulmonary dysplasia (BPD) in premature infants. Toxicol. Appl. Pharmacol. 2011, 256:83-94.
16. Das A., Kole L., Wang L., Barrios R., Moorthy B., Jaiswal A.K. BALT development and augmentation of hyperoxic lung injury in mice deficient in NQO1 and NQO2. Free Radic. Biol. Med. 2006, 40:1843-1856.
17. Emi Y., Ikushiro S., Iyanagi T. Xenobiotic responsive element-mediated transcriptional activation in the UDP-glucuronosyltransferase family 1 gene complex. J. Biol. Chem. 1996, 271:3952-3958.
18. Fanaroff A.A., Stoll B.J., Wright L.L., Carlo W.A., Ehrenkranz R.A., Stark A.R., Bauer C.R., Donovan E.F., Korones S.B., Laptook A.R., Lemons J.A., Oh W., Papile L.A., Shankaran S., Stevenson D.K., Tyson J.E., Poole W.K. Trends in neonatal morbidity and mortality for very low birthweight infants. Am. J. Obstet. Gynecol. 2007, 196(147):e141-e148.
19. Favreau L.V., Pickett C.B. Transcriptional regulation of the rat NAD(P)H:quinone reductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants. J. Biol. Chem. 1991, 266:4556-4561.
20. Fujii-Kuriyama Y., Kawajiri K. Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010, 86:40-53.
21. Ho Y.S., Dey M.S., Crapo J.D. Antioxidant enzyme expression in rat lungs during hyperoxia. Am. J. Physiol. 1996, 270:L810-L818.
22. Hsia C.C., Hyde D.M., Ochs M., Weibel E.R. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am. J. Respir. Crit. Care Med. 2010, 181:394-418.
23. Husain A.N., Siddiqui N.H., Stocker J.T. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum. Pathol. 1998, 29:710-717.
24. Jiang W., Welty S.E., Couroucli X.I., Barrios R., Kondraganti S.R., Muthiah K., Yu L., Avery S.E., Moorthy B. Disruption of the Ah receptor gene alters the susceptibility of mice to oxygen-mediated regulation of pulmonary and hepatic cytochromes P4501A expression and exacerbates hyperoxic lung injury. J. Pharmacol. Exp. Ther. 2004, 310:512-519.
25. Jobe A.J. The new BPD: an arrest of lung development. Pediatr. Res. 1999, 46:641-643.
26. Jobe A.H., Hillman N., Polglase G., Kramer B.W., Kallapur S., Pillow J. Injury and inflammation from resuscitation of the preterm infant. Neonatology 2008, 94:190-196.
27. Johansson K., Jarvliden J., Gogvadze V., Morgenstern R. Multiple roles of microsomal glutathione transferase 1 in cellular protection: a mechanistic study. Free Radic. Biol. Med. 2010, 49:1638-1645.
28. Mansour H., Levacher M., Azoulay-Dupuis E., Moreau J., Marquetty C., Gougerot-Pocidalo M.A. Genetic differences in response to pulmonary cytochrome P-450 inducers and oxygen toxicity. J. Appl. Physiol. 1988, 64:1376-1381.
29. McGrath-Morrow S., Lauer T., Yee M., Neptune E., Podowski M., Thimmulappa R.K., O'Reilly M., Biswal S. Nrf2 increases survival and attenuates alveolar growth inhibition in neonatal mice exposed to hyperoxia. Am. J. Physiol. Lung Cell. Mol. Physiol. 2009, 296:L565-L573.
30. Moorthy B. Cytochromes P450. Role in Drug Metabolism and Toxicity of Drugs and other Xenobiotics 2008, 97-135. RSC Publishing, Cambridge. C. Ioannides (Ed.).
31. Moorthy B., Nguyen U.T., Gupta S., Stewart K.D., Welty S.E., Smith C.V. Induction and decline of hepatic cytochromes P4501A1 and 1A2 in rats exposed to hyperoxia are not paralleled by changes in glutathione S-transferase-alpha. Toxicol. Lett. 1997, 90:67-75.
32. Moorthy B., Parker K.M., Smith C.V., Bend J.R., Welty S.E. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole. J. Pharmacol. Exp. Ther. 2000, 292:553-560.
33. Natarajan G., Pappas A., Shankaran S., Kendrick D.E., Das A., Higgins R.D., Laptook A.R., Bell E.F., Stoll B.J., Newman N., Hale E.C., Bara R., Walsh M.C. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum. Dev. 2012, 88(7):509-515.
34. Nebert D.W., Dalton T.P., Okey A.B., Gonzalez F.J. Role of aryl hydrocarbon receptor-mediated induction of the CYP1 enzymes in environmental toxicity and cancer. J. Biol. Chem. 2004, 279:23847-23850.
35. O'Brien P.J. Molecular mechanisms of quinone cytotoxicity. Chem. Biol. Interact. 1991, 80:1-41.
36. Park M.S., Rieger-Fackeldey E., Schanbacher B.L., Cook A.C., Bauer J.A., Rogers L.K., Hansen T.N., Welty S.E., Smith C.V. Altered expressions of fibroblast growth factor receptors and alveolarization in neonatal mice exposed to 85% oxygen. Pediatr. Res. 2007, 62:652-657.
37. Preusch P.C., Siegel D., Gibson N.W., Ross D. A note on the inhibition of DT-diaphorase by dicoumarol. Free Radic. Biol. Med. 1991, 11:77-80.
38. Rahman Q., Abidi P., Afaq F., Schiffmann D., Mossman B.T., Kamp D.W., Athar M. Glutathione redox system in oxidative lung injury. Crit. Rev. Toxicol. 1999, 29:543-568.
39. Rushmore T.H., King R.G., Paulson K.E., Pickett C.B. Regulation of glutathione S-transferase Ya subunit gene expression: identification of a unique xenobiotic-responsive element controlling inducible expression by planar aromatic compounds. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:3826-3830.
40. Saugstad O.D. Oxygen and oxidative stress in bronchopulmonary dysplasia. J. Perinat. Med. 2010, 38:571-577.
41. Shivanna B., Chu C., Welty S.E., Jiang W., Wang L., Couroucli X.I., Moorthy B. Omeprazole attenuates hyperoxic injury in H441 cells via the aryl hydrocarbon receptor. Free Radic. Biol. Med. 2011.
42. Shivanna B., Jiang W., Wang L., Couroucli X., Moorthy B. Omeprazole attenuates hyperoxic lung injury in mice via aryl hydrocarbon receptor activation, and is associated with increased expression of cytochrome P4501a enzymes. J. Pharmacol. Exp. Ther. 2011.
43. Short E.J., Klein N.K., Lewis B.A., Fulton S., Eisengart S., Kercsmar C., Baley J., Singer L.T. Cognitive and academic consequences of bronchopulmonary dysplasia and very low birth weight: 8-year-old outcomes. Pediatrics 2003, 112:e359.
44. Sinha A., Muthiah K., Jiang W., Couroucli X., Barrios R., Moorthy B. Attenuation of hyperoxic lung injury by the CYP1A inducer beta-naphthoflavone. Toxicol. Sci. 2005, 87:204-212.
45. Thatcher T.H., Maggirwar S.B., Baglole C.J., Lakatos H.F., Gasiewicz T.A., Phipps R.P., Sime P.J. Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am. J. Pathol. 2007, 170:855-864.
46. Thiel M., Chouker A., Ohta A., Jackson E., Caldwell C., Smith P., Lukashev D., Bittmann I., Sitkovsky M.V. Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol. 2005, 3:e174.
47. Tirona R.G., Kim R.B. Nuclear receptors and drug disposition gene regulation. J. Pharm. Sci. 2005, 94:1169-1186.
48. van Eijl S., Mortaz E., Versluis C., Nijkamp F.P., Folkerts G., Bloksma N. A low vitamin A status increases the susceptibility to cigarette smoke-induced lung emphysema in C57BL/6J mice. J. Physiol. Pharmacol. 2011, 62:175-182.
49. Vina J., Vento M., Garcia-Sala F., Puertes I.R., Gasco E., Sastre J., Asensi M., Pallardo F.V. l-cysteine and glutathione metabolism are impaired in premature infants due to cystathionase deficiency. Am. J. Clin. Nutr. 1995, 61:1067-1069.
50. Warner B.B., Stuart L.A., Papes R.A., Wispe J.R. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am. J. Physiol. 1998, 275:L110-L117.
51. Wright C.J., Kirpalani H. Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?. Pediatrics 2011, 128:111-126.